Cell line · CVCL_1065
A-704
Cancer cell line, Homo sapiens. Renal cell carcinoma. 32 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. A-704. Cell lines, record CVCL_1065. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1065
On this page
Cell line
As Cellosaurus gives it.
- Name
- A-704
- Accession
- CVCL_1065
- RRID
- RRID:CVCL_1065
- Synonyms
- A.704, A704
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 78Y
- Category
- Cancer cell line
- Diseases
- Renal cell carcinoma (NCIt C9385); Renal cell carcinoma (ORDO Orphanet_217071)
- Derived from
- Kidney (in situ)
- Cell type
- Epithelial cell of kidney
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers32
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Lysyl oxidase drives ccRCC progression by coordinating HIF-2α transcription program with tumor microenvironment. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CD8+ T cell-derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells. | Sci Adv | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Requirement for Cyclin D1 Underlies Cell-Autonomous HIF2 Dependence in Kidney Cancer. | Cancer Discov | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Loss of SETD2 in wild-type VHL clear cell renal cell carcinoma sensitizes cells to STF-62247 and leads to DNA damage, cell cycle arrest, and cell death characteristic of pyroptosis. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| APOBEC3C-mediated NF-κB activation enhances clear cell renal cell carcinoma progression. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Pan-cancer proteomic map of 949 human cell lines. | Cancer Cell | 2022 | Cellosaurus cites it | PubMed | |
| Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma. | Mol Cancer Res | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Profiling of diverse tumor types establishes the broad utility of VHL-based ProTaCs and triages candidate ubiquitin ligases. | iScience | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Identification of PARP-7 substrates reveals a role for MARylation in microtubule control in ovarian cancer cells. | Elife | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Quantitative Proteomics of the Cancer Cell Line Encyclopedia. | Cell | 2020 | Cellosaurus cites it | PubMed |
1 to 10 of 32
See all 32 papersRelatives0
None in this release.
Cell banks8
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-7911 | Discontinued | Cellosaurus |
| ATCC | HTB-45 | ATCC | |
| CLS | 300217 | CLS | |
| ECACC | 93020513 | ECACC | |
| ICLC | HTL95007 | ICLC | |
| IZSLER | BS TCL 117 | Cellosaurus | |
| KCLB | 30045 | KCLB | |
| NCI-DCTD | A704 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1065
GET https://conductscience.org/api/cell-lines/v1/CVCL_1065/papers?page=2